Analyst Ratings for EPIRUS Biopharmaceuticals (EPRS)

EPRS Rating Summary

  |   Expand Research on EPRS
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 0 / 10   Percentile Rank: 0%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/16/2016 Leerink N/A Downgrade Market Perform
(Outperform)		 N/A
(N/A)		 0.78
(0.14)		 -82.05% Details
5/11/2016 BTIG N/A Downgrade Neutral
(Buy)		 N/A
(N/A)		 1.08
(0.14)		 -87.04% Details